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Background: NAC is a 35amino-acid peptide which 
has been isolated from the intoluble core of Alzheimerk 
disease (Al)) amyloid plaque. It is a fragment of a-synu- 
clein (or NACP), a neuronal protein of unknown func- 
tion. We noted a striking sequence similarity between 
NAC, the carboxyl terminus of the P-amyloid protein, 
and a region of the scrapie prion protein (PrP) which has 
been implicated in amyloid formation. 
Results: NAC was prepared by chemical synthesis and 
was found to form amyloid fibrils via a nucleation- 
dependent polymerization mechanism. NAC amyloid 
fibrils effectively seed pl-40 amyloid formation. Amyloid 
fibrils comprising peptide models of the l~on~ologous 
p and PrP sequences were also found to seed amyloid 
formation by NAC. 
Conclusions: The in vitro model studies presented here 
suggest that seeding of NAC amyloid formation by the 
P-amyloid protein, or seeding of amyloid fibrils of the p- 
amyloid protein by NAC, may occur in viva. 
Accumulation of ordered NAC aggregates in the synapse 
may be responsible for the neurodegeneration observed 
in AD and the prion disorders. Alternatively, neurode- 
generation may be caused by the loss of a-synuclein 
(NACP) function. 
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Introduction 
Amyloid plaque is characteristic of Alzheimer’s disease 
(AD) [l-3] .The major protein components of the insol- 
uble core ofAD amyloid plaque are short peptide frag- 
ments (39-43 amino acids in length) of the p protein 
(also called P-amyloid, P/A4, PAl: or AP) (Fig. 1) [4-81. 
Recently, the peptide NAC (non-AP component ofAD 
amyloid) was identified as an intrinsic component of the 
amyloid plaque core based on its copurification with the 
p protein and immunological localization on amyloid 
fibrils by electron microscopy (EM) [9]. NAC is a 
peptide of at least 35 amino acids (Fig 2). It is a fragment 
of a 14@amino-acid precursor, a protein known as 
NACP or cr-synuclein, which is localized to the pre- 
synaptic nerve terminal [9-131 (Fig. 1). Interestingly, 
NACP is found primarily in the regions of the brain that 
degenerate in AD [ 131. 
The prion diseases (for example, scrapie, kuru and 
Creutzfeldt-Jakob disease) are also characterized by 
abnormal protein deposition in brain tissue, in this case, 
of a species known as the prion protein (PrP) [l4].We 
have noted a sequence similarity between PrP and the p 
protein which may direct amyloidogenesis [15, 161. Both 
the p protein 1171 and peptides based on the PrP 
sequence [I81 exhibit neurotoxicity in cell culture. 
Overexpression of the p protein in transgenic mice 
induces amyloid plaque formation [19] and neuro- 
degeneration [20]. Aggregation of these proteins is a 
requirement for neurotoxicity in vitro 1211. Since 
amyloid deposits may be causative in neurodegenerative 
diseases [I ,221, it is critical to understand the mechanism 
by which amyloid deposition occurs, and the role of 
endogenous factors such as NAC. 
The formation of p and PrP amyloid fibrils, like a crys- 
tallization, appears to occur by a nucleation-dependent 
mechanism (Fig. 3) [16,23,24]. Nucleus formation 
involves a series of thermodynamically-unfavorable 
protein association equilibria (K,l + 1). Once a nucleus 
has formed, further addition of monomer is thermody- 
namically favorable (Kg + 1). Consequently, at a protein 
concentration slightly exceeding the thermodynamic 
solubility (critical concentration), amyloid formation 
exhibits a lag time before rapid fibril growth. Addition of 
preformed fibrils (or ‘seeds’) can decrease the length of 
the lag time by eliminating the need for a slow nucle- 
ation step. Seeds can be homogeneous (derived from an 
identical molecule of peptide or protein) or hetero- 
geneous (derived from a different molecular species). 
Alternatively, endogenous factors could inhibit nucleus 
formation and/or fibril growth [25]. 
Here we show that a synthetic prptide based on the 
minimal 35-amino-acid NAC sequence can form amyloid 
tibrils via a nucleation-dependent kinetic mechanism. We 
examined the effect of NAC on the solubility and the 
aggregation kinetics of amyloidogenic p- and PrP-derived 
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peptides (Fig. 2), and viic~ UCKSL It has been proposed that 
NAC could promote the formation of p protein amyloid 
iul viva [9, 261. Our in vitro results indicate that NAC 
amyloid effectively seeds P-protein fibril formation, and, 
in addition, that NAC amyloid formation can be seeded 
by either p or LW peptide seeds.These results may shed 
light on the role of NAC in the pathogen& ofAD and 
related neurodcgenerative disorders. 
Results 
NAC peptide aggregates from supersaturated solution to 
form amyloid fibrils 
The precise length of NAC associated with p protein 
amyloid fibrils has not been determined 191. However, a 
minimal sequence of 35 amino acids was determined by 
enzymatic digestion of amyloid plaque core and con- 
firmed by cDNA sequencing of NACP We therefore 
synthesized a 35-amino-acid NAC peptide (Fig. 2). A 
supersaturated solution of this NAC peptide was stirred 
and aggregation was monitored by turbidity measure- 
ments [15,23]_ The precipitate was isolated by centrifuga- 
tion and visualized by electron microscopy (EM) (Fig. 
4a), showing that it formed ordered amyloid flbrils.The 
peptide film stained with Congo Red dye, like true 
amyloid fibrils, and, under a polarizing light microscope, 
exhibited the birefringence characteristic of amyloid 
[27,28]. The Fourier transfbrm infrared (FTIR) spectrum 
of fibrillar NAC was dominated by two low-frequency 
absorption amide I bands (1633 and 1627 cm-‘), 
indicative of antiparallel P-sheet structure (Fig. 4b) [as]. 
The solubility of p and PrP peptides does not significantly 
decrease in the presence of NAC 
We compared the solubility of the p and PrP peptides 
alone with their solubility in the presence of another 
amyloidogcnic peptide. Fibrils were prepared by stirring 
supersaturated mixtures, containing one peptide (40 PM) 
or equimolar in two peptides (40 p,M each).After aggre- 
gation, the concentration of each peptide in the soluble 
Fig. 1. A comparison of sequences from 
PI-43, oL-synuclein, and PrP. Sequence 
identities are highlighted. The box incli- 
cates the eight-residue hydrophobic 
region with local sequence homology. 
The Al 17V mutation (asterisk) segre- 
gates with the human prion disease 
Gerstmann-StrausslerScheinker syn- 
drome (GSS) 131,321. 
phase was compared using quantitative amino acid analy- 
sis. As well as the p and 1’1-1’ peptidcs themselves, we also 
tested several shortened forms of the the p peptide and a 
mutant form of the PrP peptide (Ala1 17+Val, Al 17V). 
The solubility of isolated peptidcs, in p,M was: pl-40, 
0.9kO.X; p26-40, 6.2k1.2; P26-42, 3.4kO.3; p26-43, 
3.1?0.2; PrP106-126, 15.9+2.5; PrP106-126A117V, 
X.7? 1 .O.The individual measured solubilities in mixtures 
of p and PrP-derived peptidcs were indistinguishable 
fi-om the solubilities of the isolated peptides (small effects 
are not measurable by this method, however, and these 
values may not represent the true thermodynamic solu- 
bility [29,30]). In contrast, mixtures of NAC with p or 
PrP peptides produced anomalous effects; although the 
solubility of NAC was not significantly changed by the 
presence of other peptides (10.9&0.8 PM), some of the 
p and Prl’ peptides had increased solubility in the pres- 
ence of NAC (solubility in the presence of 40 p,M 
NAC, in PM: pl-40, 0.5?0.1; p26-40, 11.8k1.2; 
p26-42, 7.2kO.3; p26-43, 6.5kO.5; PrPl (K-126, 
24.1k3.0; PrP106-126A117V, 16.4k2.5). 
Amyloid formation by NAC is nucleation-dependent and 
can be seeded by NAC fibrils 
Supersaturated solutions of NAC were metastable. Amyloid 
formation by NAC at 80 FM did not proceed immedi- 
ately but exhibited a lag time (666 ? 88 min) characteristic 
of nucleation-dependent polymerization (Fig. 5a).The lag 
time preceding NAC fibril formation could be eliminated 
by addition of NAC seed fibrils (20 PM) (Fig Sa). 
PI-40 Amyloid fibril formation can be seeded by NAC fibrils 
The rates of amyloid formation from a supersaturated 
solution of pl-40 (80 FM) in the presence and the 
absence of NAC seed fibrils (20 PM) were compared by 
monitoring the increase in turbidity (Fig. 5b); the turbid- 
ity due to the presence of the seed peptide was subtracted 
from all data points. In the presence of NAC, the length 
of the nucleation phase preceding amyloid formation 
1 26 43 
l-43 H2N-DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAllGLMVGGVVIAT-CO2H 
26-43 AcHN-SNKGAIIGLMVGGVVIAT-C02H 
26-42 AcHN-SNKGAIIGLMVGGVVIA-CO H 
26-40 AcHN-SNKGAIIGLMVGGVV-CO2tf 
NAC H2N-:QVTNVGGAVVTGVTAVAQKTVEGAGSl AAATGF;-C02H 
106 117 126 
PrP106-126 AcHN-KTNMKHMAGAAAAGAVVGGLG-CONH2 
PrP106-126A717V AcHN-KTNMKHMAGAAVAGAVVGGLG-CONH2 
* 
Fig. 2. The sequences of NAC, PrP, the 
p protein and corresponding truncated 
model peptides. NAC comprises 
residues 61-9.5 of human a-synu- 
clein/NACP. The sequence difference 
between PrPlO6-126 and PrPlO6- 
126A117V is marked with an asterisk. 
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Fig. 3. A general mechanism for nucle- 
ation-dependent amyloid fibril forma- 
tion, including a working hypothesis for 
NAC. Nucleation (association equilibria 
K, 4 1) and growth steps (association 
equilibria K, p 1) are indicated. A 
similar mechanism is applicable for PrP. 
Heterogeneous seeding which is 
demonstrated herein to be effective, 
albeit less effective than homogeneous 
seeding, may be critical in viva. 
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decreased by more than 50 o/;, (Table 1, 8). A similar effect 
was observed for model peptide @26-40 seeded with 
NAC (Table 1, h). In contrast, PrP106-126 and 
l’rP106-126A117V were not seeded by NAC (data not 
shown).The prion peptides showed no significant ability 
to seed p26-40 (Table I, ij) or pl-40 (data not shown). 
NAC fibril formation can be seeded by p and PrP 
peptide fibrils 
The p protein analogs shown in Table 1 seeded NAC 
amyloid formation, albeit less efficiently than did NAC 
itself (Fig. 5). Short p (pl-40 and the model peptide 
p26-40), which d oes not contain the entire homologous 
sequence, was a less effective seed than models of long p 
(p26-42, P2h-43) (T bl a e 1, a-d). Addition of fibrils 
comprising PrP106-226 and PrPlO6-126A117V (a 
mutation which segregates with Gerstmanri- 
Strausslel--Scheinker syndrome [31,32]) also led to a 
decrease in the observed nucleation time (Fig. 5n; Table 
1, e-f). No significant difference between the abilities of 
the Ala- and Val- containing variants to seed NAC was 
observed. Neither NAC nor p was an effective cecd for 
either 1+-t- analog (data not shown). 
Discussion 
Amyloid plaque is the pathological hallmark of AID [1,2 I. 
The recent discovery of NAC as an intrinsic component 
of the insoluble amyloid plaque core suggests that this 
peptide may be important in AD pathogenesis. While ;I 
number of components (for example, apolipoprotein E 
[33,34], a,-antichymotrypsin 1351 and heparan sulfate 
proteoglycan 1361, among others) are loosely associated 
with plaques, NAC copurifies with the p protein even in 
the presence of SDS, and can be localized to amyloid 
fibrils using electron microscopy 191. The primary 
sequence of an amino-terlninal portion of NA(: 
(residues 66-73) resembles the amyloidogenic carboxyl 
terminus of the p protein (residues 36-43) (Fig. l).This 
is a critical region of the p protein: truncated variants of 
/3, which form amyloid more slowly irr vifro 1231, are the 
primary circulating proteins while the longer, more 
rapidly aggregating variants are the primary plaq~~c pro- 
teins 1371. A similar sequence is also found in a region 
of the prion protein (Pi-e residues 117-l 24, Fig. 1) Thr 
substitution ofVa1 for Ala at codon 117 of PrP is found 
in Gerstmam-Straussler-Scheinker syndrome (GSS) 
13 1 ,321. A peptide containing &is region (PrPlM’-126) 
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(a) 
Wavenumber (cm-‘) 
Fig. 4. The NAC peptide forms amyloid fibrils. (a) Electron micro- 
graph of NAC fibrils (Bar = 1000 A). (b) Upper trace: FTIR spec- 
trum of NAC fibrils; lower trace: Fourier-deconvoluted spectrum. 
is known to form amyloid fibrils and is neurotoxic [18]. 
The sequence similarities suggest that specific hydropho- 
bic interactions between NAC (or NACP), Prl’, and the 
P protein could occur in viva. 
A 35-amino-acid peptide with the minimal NAC 
sequence was chemically synthesized on the solid phase. 
When a supersaturated solution of this peptide in phos- 
phate buffered saline (PBS) was prepared, NAC formed 
ordered amyloid tibrils which fit the characteristic defin- 
ition of amyloid: unbranched, twisted fibrils as viewed by 
EM (Fig. 4a), and staining and birefringence under polar- 
ized light with the dye Congo Red 1221. Fourier tran- 
form IR (FTIR) indicates predominantly antiparallel 
P-sheet conformation (Fig. 4b) [2X]. 
The colocalization of NAC and p in amyloid plaque 
could be due to the formation of highly insoluble co- 
aggregates of these two species 129,301. To test this 
hypothesis, we compared the solubility of each isolated 
peptide to the solubility of that peptide in the presence of* 
one other peptide. No evidence was found for the forma- 
tion of a stable coaggregate. In fact, several p protein- and 
PrP-derived peptides actually showed an increase in solu- 
bility in the presence of NAC.This phenomenon is not 
easily interpreted, and an effect on solubility does not 
necessarily correlate with the ability to serve as a seed. 
The kinetics of amyloid formation from a supersaturated 
solution of NAC indicate that this process is a nucle- 
ation-dependent polymerization (Fig. 3). An identical 
mechanism governs amyloid formation by a number of 
amyloidogenic species [15,16,23,24,38]. One feature of 
this mechanism is that addition of a preformed fibril 
(seed) eliminates the need for nucleation.Thus, addition 
of NAC fibrils to a supersaturated NAC solution elimi- 
nated the lag time completely, and immediate seeded 
growth was observed (‘homogeneous seeding’) (Fig. 5a). 
Heterogeneous seeding was also observed. Fig. 5b shows 
the result of seeding pl-40 with synthetic NAC. 
Addition of NAC seed fibrils led to a significant decrease 
in the lag time observed before pl-40 fibril growth. In 
this case, seeded growth does not occur immediately, as it 
does in self-seeding experiments; seeding manifests itself 
as a reduction, rather than an elimination, of the 
observed lag time. This observation is consistent with the 
idea that a greater degree of primary sequence homology 
leads to more efficient seeding. Seeding is a chemically 
discriminating event; small changes in primary sequence 
can eliminate the ability of a peptide to serve as a seed 
[ 15,16,24]. This property has been demonstrated using a 
series of peptides derived from a similar amyloidogenic 
sequence 1151. Our experimental data thus support the 
hypothesis 19,261 that NAC, which comprises 10 % of 
the total protein concentration in the plaque, could 
promote p protein amyloid formation in vim (Fig. 3). 
A second possibility is that the promotion of NAC 
amyloid formation by p or prion proteins could be path- 
ogenic. In Fig 5a, we show the results of heterogeneous 
seeding of NAC amyloid formation. Peptides derived 
from both p protein $1-40, p26-40, p26-42, p26-43) 
and prion protein (PrP106-126, PrP106-126Al17V) 
sequences exhibited the ability to seed NAC amyloid 
formation in our in vitro assay (Table 1). The ‘long p’ 
models, which have a greater sequence homology to 
NAC, were more efficient seeds, once again support- 
ing the importance of the sequence homolo,T. Thus, 
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Fig. 5. Representative kinetics for amyloid fibril formation mea- 
sured by turbidity (400 nm). The vertical axis indicates the 
increase in turbidity relative to an initial measurement. The tur- 
bidity due to added seeds was subtracted. (a) Unseeded NAC 
(W); NAC self-seeded (0); NAC seeded with @l-40 (0); NAC 
seeded with PrP106-126A117V (A). (b) pl-40 unseeded (m); 
pl-40 seeded with NAC (0). Calculated lag times and standard 
deviations are given in Table 1. 
aggregation of NAC itself may be promoted by other 
amyloid proteins irz viva (Fig. 3). 
This possibility leads back to the role of NACP/ol-synu- 
clein, the synaptic protein from which NAC is derived. 
Although the function of NACP is unknown, it is found 
primarily in brain tissue, and is localized within neurons 
at the presynaptic nerve terminal [lo, II,1 3,391. Synaptic 
amyloid deposition may be a common theme among 
amyloid-characterized neurodegenerative disorders [13]. 
Production of NAC in high local concentration at the 
synapse could seed amylold formation and have a neuro- 
toxic effect 19,261. Alternatively, p amyloid (or PrPsC) 
could seed the aggregation of NAC or NACP Further 
information on the structure and fLmction of NACP/(r- 
synuclein will be required to elucidate the possible role 
of tllis protein in neurodegenerative disorders. 
Significance 
Brain amyloid is the major pathological diagnostic 
feature ofAD, although there is no consensus as to 
Table 1. Nucleation (lag) times measured by turbidity. 
i 
Solution Seed 
(80 PM) (20 PM) 
Lag time 
relative to unseeded* 
NAC 
NAC 
NAC 
NAC 
NAC 
NAC 
p1-40 
826-40 
p26-40 
p2 6-40 
p1-40 0.70 (0.02) 
/32 6-40 0.79 (0.19) 
p2 6-42 0.47 (0.09) 
p26-43 0.44 (0.14) 
PrPlO6-126 0.71 (0.22) 
PrPlO6-126A117V 0.60 (0.12) 
NAC 0.4 (0.1) 
NAC 0.60 (0.04) 
PrPlO6-126 0.9 (0.2) 
PrPlO6-126A117V 1.1 (0.3) 
*Lag time of aggregating peptide solutions (80 PM) in the 
presence of fibrils (20 )LM) as a seed. Data shown are an 
average over at least 3 trials. Each value was determined by 
solving the best fit line to the growth phase of the aggrega- 
tion curve for y = 0 and is presented as a fraction relative to 
unseeded lag times (in min (+S.D.)): NAC, 666 (88); pl-40, 
119 (25); p26-40, 115 (3). 
whether these plaques cause disease [l]. Evidence 
is accumulating that suggests a possible causative 
role for amyloid plaque and its primary protein 
component, the p protein. In addition to AD, 
which is characterized by p protein amyloid for- 
mation, other neurodegenerative diseases are char- 
acterized by abnormal ordered-protein aggregates, 
for example, the prion diseases [14]. It is therefore 
important to study the mechanism of amyloid 
deposition, as well as to determine the role of 
factors which might affect this process. One such 
factor is the non-A6 component of AD amyloid 
(NAC). Although a number of proteins are associ- 
ated with the plaques in viva, only NAC has been 
identified as a second intrinsic component of the 
insoluble plaque core. 
We have shown that NAC forms ordered fibrils 
which meet the characteristic definition of 
amyloid. Amyloid formation by NAC proceeds 
via a nucleation-dependent mechanism similar to 
a crystallization. Addition of a preformed NAC 
fibril seeds amyloid formation by eliminating the 
need for a nucleation step. 
Seeding is a sequence-dependent event; a region of 
high local sequence homology between p, PrP, and 
NAC suggests to us that specific local interactions 
may lead to heterogeneous seeding between these 
species. In fact, we find that NAC seeds pl-40 
amyloid formation, and both fll-40 and 
PrP106-126 seed NAC amyloidogenesis. However, 
neither NAC nor p seeds PrP. 
These results suggest that NAC may be a common 
target or trigger for amyloid plaque formation in 
AD. The identification of the precursor to NAC as 
NACP or a-synuclein, a synaptic protein, suggests 
168 Chemistry & Biology 1995, Vol 2 No 3 
a connection between these proteins and the 
neurodegeneration observed in AD [13,26]. 
Aggregation of NAC, or the loss of NACP/ 
cx-synuclein function, could be pathogenic. 
Materials and methods 
Peptide synthesis, purification, and characterization 
NAC was synthesized by standard C)-fluorcnylmethosycar- 
bony1 (Frnoc) chemistry on the Wang resin (Fmoc-V&resin, 
Novabiochem, La Jolla, CA) and purified to homogeneity by 
reverse-phase HPLC (watcr/acetonitrile/0.1 ‘%I trifluoro- 
acetic acid). Purity of the peptidc was determined to bc 
>90 % by reverse-phase HPLC on a C4 analytical column 
(5-PmTP, 0.46x25 crn,Vydac, Hesperia, CA) under isocratic 
conditions (70 ‘% H,0/30 ‘% acetonitrile, 2 ml mill-’ flow 
rate, Kv=17-20 ml). Amino acid analysis (Applied 
Biosystems Model 420 PTH amino acid analyzer), amino 
acid sequencing (Applied Biosystem Model 477A protein 
sequencer), and plasma desorption mass spectroinetry 
(PDMS) were consistent with the desired product: (M+H)+, 
calc’d. 3262.7, found 3258.4. p26-40, p26-42, @26-43, 
PrP106-126, and PrPlO6-126A117V were prepared by 
methods reported previously [16,23]. 61-40 wa\ purchased 
fro111 Bachem (Torrance, CA). 
Electron microscopy (EM) and Congo Red (CR) staining 
Samples for EM were prepared by stirring supersaturated 
solutions of peptide (80 PM) in 100 mM NaCl/8.2 mM 
Na2HP0,/1.S mM NaH,PO,, pH 7.4/10 ‘%I dimethyl sulf- 
oxide (DMSO) (hereaftcl- referred to as the standard buffer). 
EM samples were placed on carbon-coated copper grids, neg- 
atively stained with 2 “/I uranyl acetate, and viewed at 
6OK-120K on a JEOL 1200 CX EM at SO kV. CK staining 
of aggregated peptide? dried on a glass microscope slide was 
performed as described 1151. 
FTIR spectroscopy 
Aggregated peptides were centrifuged at 4000 rprn fol 
10 min and spread on a CaF2 plate. Aftcl- air drying, the 
infrared spectra were recorded on a Perkin-Elmer 1600 series 
FTIR spectrometer. 
Solubility 
A supersaturated solution of peptlde (40 FM) or mixtures of two 
pcptido (40 PM each) in standard buffer was stirred at 1800 rpnl 
for 72 h. The suspension was filtered through a Millex-GV 
0.22-~~111 aqueous filter (Millipore).Total pcptidc concentrations 
were determined by quantitative amino acid analysis. and the rel- 
ative ratios were determined based on unshared amino acids (data 
shown represent an average of three trials). 
Aggregation kinetics and seeding experiments 
A supersaturated solution of peptide (80 PM) in standard 
buffer was prepared by addition of pcptide dissolved in 
DMSO to phosphate buffer and stirred continuously at 
1800 rpm (1550 rpm for pl-40 and @26-40). Samples were 
vortexed briefly (except for pl-40 and p26-40) and aggre- 
gation was measured by turbidity at 400 nm versus a buffer 
blank. Seeding experiments were initiated by addition of a 
suspension of fibrils (20 +M final) f ram a previous aggregation 
trial.The turbidity due to the seed peptide was accounted for 
by blanking on the suspension of seeds in buffer inuncdiately 
before addition of the DMSO stock solution. 
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